Yixintang Pharmaceutical (SZ:002727) Xin Lang Zheng Quan·2025-10-30 01:20Core Viewpoint - YXTT experienced a slight decline of 0.93% on October 29, with a trading volume of 76.68 million yuan, indicating a low financing balance relative to its market value [1][2]. Financing Summary - On October 29, YXTT had a financing buy-in amount of 9.95 million yuan and a financing repayment of 7.95 million yuan, resulting in a net financing buy of 1.99 million yuan. The total financing and securities balance reached 226 million yuan, which is 2.79% of its market value, indicating a low level compared to the past year [1]. - The financing balance of 226 million yuan is below the 50th percentile level over the past year, suggesting a conservative financing approach [1]. Securities Lending Summary - On the same day, YXTT repaid 700 shares and sold 500 shares in securities lending, with a selling amount of 6,905 yuan. The remaining securities lending volume was 53,500 shares, with a balance of 738,800 yuan, also below the 40th percentile level over the past year [1]. Company Overview - YXTT, established on November 8, 2000, and listed on July 2, 2014, is based in Kunming, Yunnan Province. The company primarily engages in pharmaceutical retail and wholesale, with its revenue composition being 75.03% from Western and Chinese medicines, 9.86% from other products, 8.56% from traditional Chinese medicine, and 6.55% from medical devices and disinfectants [1]. Financial Performance - For the first half of 2025, YXTT reported a revenue of 8.914 billion yuan, a year-on-year decrease of 4.20%, and a net profit attributable to shareholders of 250 million yuan, down 11.44% year-on-year [2]. - Since its A-share listing, YXTT has distributed a total of 2.023 billion yuan in dividends, with 764 million yuan distributed over the past three years [2]. Shareholder Structure - As of June 30, 2025, YXTT had 33,900 shareholders, a decrease of 5.42% from the previous period, with an average of 11,712 circulating shares per shareholder, an increase of 5.73% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the third-largest shareholder, holding 18.5744 million shares, a decrease of 21.1993 million shares from the previous period. New entrants among the top shareholders include several mutual funds from GF Securities [3].